RESEARCH-USE BIOSIMILAR ANTIBODY
Durvalumab
Monoclonal antibody · IgG1
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody. Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively.
TARGETPDL1
YMonoclonal antibody
CATALOGSC-BS-605
CATALOG NUMBERSC-BS-605
MOLECULAR WEIGHTApprox. 146.32 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody. Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively.
Durvalumab is a recombinant research-use antibody directed against PDL1.